Identification of a circRNA-miRNA-mRNA network to explore the effects of circRNAs on renal injury in systemic lupus erythematosus

References

• Garchow B, Maque Acosta Y, Kiriakidou M. HIF-1α and miR-210 differential and lineage-specific expression in systemic lupus erythematosus. Mol Immunol. 2021;133:1–10.
   PubMed Web of Science ®Google Scholar
• Sawada T, Fujimori D, Yamamoto Y. Systemic lupus erythematosus and immunodeficiency. Immunol Med. 2019;42(1):1–9.
   PubMedGoogle Scholar
• Parikh SV, Almaani S, Brodsky S, et al. Update on lupus nephritis: core curriculum 2020. Am J Kidney Dis. 2020;76(2):265–281.
   PubMed Web of Science ®Google Scholar
• Li YJ, Wu HH, Liu SH, et al. Polyomavirus BK, BKV microRNA, and urinary neutrophil gelatinase-associated lipocalin can be used as potential biomarkers of lupus nephritis. PLoS One. 2019;14(1):e0210633.
   PubMed Web of Science ®Google Scholar
• Arazi A, Rao DA, Berthier CC, et al. The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol. 2019;20(7):902–914.
   PubMed Web of Science ®Google Scholar
• Guo G, Wang H, Ye L, et al. Hsa_circ_0000479 as a novel diagnostic biomarker of systemic lupus erythematosus. Front Immunol. 2019;10:2281.
   PubMed Web of Science ®Google Scholar
• Zhang MY, Wang JB, Zhu ZW, et al. Differentially expressed circular RNAs in systemic lupus erythematosus and their clinical significance. Biomed Pharmacother. 2018;107:1720–1727.
   PubMed Web of Science ®Google Scholar
• Huang Z, Pang G, Huang YG, et al. miR-133 inhibits proliferation and promotes apoptosis by targeting LASP1 in lupus nephritis. Exp Mol Pathol. 2020;114:104384.
   PubMed Web of Science ®Google Scholar
• Abdul-Maksoud RS, Rashad NM, Elsayed WSH, et al. Circulating miR-181a and miR-223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis. J Gene Med. 2021;23(5):e3326.
   PubMed Web of Science ®Google Scholar
• Liao W, He XJ, Zhang W, et al. MiR-145 participates in the development of lupus nephritis by targeting CSF1 to regulate the JAK/STAT signaling pathway. Cytokine. 2022;154:155877.
   PubMed Web of Science ®Google Scholar
• Xu H, Chen W, Zheng F, et al. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network in systemic lupus erythematosus. Lupus. 2020;29(4):398–406.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu Y, Shi G. The circRNA-miRNA-mRNA regulatory network in systemic lupus erythematosus. Clin Rheumatol. 2021;40(1):331–339.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288–291.
   PubMed Web of Science ®Google Scholar
• Davidson A, Aranow C, Mackay M. Lupus nephritis: challenges and progress. Curr Opin Rheumatol. 2019;31(6):682–688.
   PubMed Web of Science ®Google Scholar
• Soliman S, Mohan C. Lupus nephritis biomarkers. Clin Immunol. 2017;185:10–20.
   PubMed Web of Science ®Google Scholar
• Adhya Z, El Anbari M, Anwar S, et al. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Lupus. 2019;28(6):713–721.
   PubMed Web of Science ®Google Scholar
• Manoharan A, Madaio MP. Biomarkers in lupus nephritis. Rheum Dis Clin North Am. 2010;36(1):131–143, ix.
   PubMed Web of Science ®Google Scholar
• Miguel DF, Terreri MT, Pereira RMR, et al. Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis. Adv Rheumatol. 2020;60(1):10.
   PubMedGoogle Scholar
• Shang Z, Li H. Altered expression of four miRNA (miR-1238-3p, miR-202-3p, miR-630 and miR-766-3p) and their potential targets in peripheral blood from vitiligo patients. The Journal of Dermatology. 2017;44(10):1138–1144.
   PubMed Web of Science ®Google Scholar
• Hayakawa K, Kawasaki M, Hirai T, et al. MicroRNA-766-3p contributes to anti-Inflammatory responses through the indirect inhibition of NF-κB signaling. Int J Mol Sci. 2019;20(4):809.
   Web of Science ®Google Scholar
• Liu Y, Han Y, Qu H, et al. Correlation of microRNA expression profile with clinical response to tumor necrosis factor inhibitor in treating rheumatoid arthritis patients: a prospective cohort study. J Clin Lab Anal. 2019;33(7):e22953.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhou F, Yang Y, et al. MiR-409-3p and MiR-1896 co-operatively participate in IL-17-induced inflammatory cytokine production in astrocytes and pathogenesis of EAE mice via targeting SOCS3/STAT3 signaling. Glia. 2019;67(1):101–112.
   PubMed Web of Science ®Google Scholar
• Omidi F, Hosseini SA, Ahmadi A, et al. Discovering the signature of a lupus-related microRNA profile in the gene expression omnibus repository. Lupus. 2020;29(11):1321–1335.
   PubMed Web of Science ®Google Scholar
• Guan J, Wang G, Tam LS, et al. Urinary sediment ICAM-1 level in lupus nephritis. Lupus. 2012;21(11):1190–1195.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Zhao F, Liu C, et al. LncRNA FOXD2-AS1 promotes cell proliferation and invasion of fibroblast-like synoviocytes by regulation of miR-331-3p/PIAS3 pathway in rheumatoid arthritis. Autoimmun Rev. 2021;54(5):254–263.
   Google Scholar
• Lucafò M, Sicari D, Chicco A, et al. miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway. Cancer Chemother Pharmacol. 2020;86(3):361–374.
   PubMed Web of Science ®Google Scholar
• Ormseth MJ, Solus JF, Sheng Q, et al. Development and validation of a MicroRNA panel to differentiate between patients with rheumatoid arthritis or systemic lupus erythematosus and controls. J Rheumatol. 2020;47(2):188–196.
   PubMed Web of Science ®Google Scholar
• Zu B, Liu L, Wang J, et al. MiR-140-3p inhibits the cell viability and promotes apoptosis of synovial fibroblasts in rheumatoid arthritis through targeting sirtuin 3. J Orthop Surg Res. 2021;16(1):105.
   PubMed Web of Science ®Google Scholar
• Rudnicki M, Perco P, D Haene B, et al. Renal microRNA- and RNA-profiles in progressive chronic kidney disease. Eur J Clin Invest. 2016;46(3):213–226.
   PubMed Web of Science ®Google Scholar
• Akbaba TH, Akkaya-Ulum YZ, Tavukcuoglu Z, et al. Inflammation-related differentially expressed common miRNAs in systemic autoinflammatory disorders patients can regulate the clinical course. Clin Exp Rheumatol. 2021;39(Suppl 132, 5):109–117.
   PubMed Web of Science ®Google Scholar
• Guo J, Hao J, Jiang H, et al. Proteasome activator subunit 3 promotes pancreatic cancer growth via c-Myc-glycolysis signaling axis. Cancer Lett. 2017;386:161–167.
   PubMed Web of Science ®Google Scholar
• Nikaido T, Shimada K, Shibata M, et al. Cloning and nucleotide sequence of cDNA for Ki antigen, a highly conserved nuclear protein detected with sera from patients with systemic lupus erythematosus. Clin Experim Immunol. 1990;79(2):209–214.
   PubMed Web of Science ®Google Scholar
• Sun J, Luan Y, Xiang D, et al. The 11S proteasome subunit PSME3 is a positive feedforward regulator of NF-κB and important for host defense against bacterial pathogens. Cell Rep. 2016;14(4):737–749.
   PubMed Web of Science ®Google Scholar
• Yan Q, Sharma-Kuinkel BK, Deshmukh H, et al. Dusp3 and Psme3 are associated with murine susceptibility to Staphylococcus aureus infection and human sepsis. PLoS Pathog. 2014;10(6):e1004149.
   PubMed Web of Science ®Google Scholar
• Boulpicante M, Darrigrand R, Pierson A, et al. Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3. Oncoimmunology. 2020;9(1):1761205.
   PubMed Web of Science ®Google Scholar
• Cascio P. PA28γ: new insights on an ancient proteasome activator. Biomolecules. 2021;11(2):228.
   PubMed Web of Science ®Google Scholar
• Alexopoulos E, Seron D, Hartley RB, et al. Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int. 1990;37(1):100–109.
   PubMed Web of Science ®Google Scholar
• Kim J, Jeong JH, Jung J, et al. Immunological characteristics and possible pathogenic role of urinary CD11c + macrophages in lupus nephritis. Rheumatol. 2020;59(8):2135–2145.
   PubMed Web of Science ®Google Scholar